It is suggested NF‐κB and TLR4 are activated to cause the airway inflammation, while administration of anti‐HMGB1 antibodies or ethyl pyruvate (EP) reduces airway inflammation and remodeling in mice asthma models induced by OVA.95, 96. This evidence concerns the gene TLR4 and asthma.